Publicaciones en colaboración con investigadoras/es de Hospital de Jerez (18)

2023

  1. Correction: Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial (Surgical Endoscopy, (2023), 37, 9, (7317-7324), 10.1007/s00464-023-10278-5)

    Surgical Endoscopy

  2. Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial

    Surgical Endoscopy, Vol. 37, Núm. 9, pp. 7317-7324

2022

  1. Health related quality of life following open versus minimally invasive total gastrectomy for cancer: Results from a randomized clinical trial

    European Journal of Surgical Oncology, Vol. 48, Núm. 3, pp. 553-560

  2. Non-metastatic castration-resistant prostate cancer: management recommendations

    Actas Urologicas Espanolas, Vol. 46, Núm. 4, pp. 193-213

2021

  1. Correction to: Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial (Gastric Cancer, (2021), 24, 1, (258-271), 10.1007/s10120-020-01109-w)

    Gastric Cancer

  2. Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial

    Gastric Cancer, Vol. 24, Núm. 1, pp. 258-271

  3. Trends and outcome of neoadjuvant treatment for rectal cancer: A retrospective analysis and critical assessment of a 10-year prospective national registry on behalf of the Spanish Rectal Cancer Project

    European Journal of Surgical Oncology, Vol. 47, Núm. 2, pp. 276-284

2018

  1. Actualización del papel de la quimioterapia endovesical en el cáncer de vejiga no músculo-invasivo

    Actas Urologicas Espanolas

  2. Radio-223 en la secuencia terapéutica del cáncer de próstata resistente a la castración metastásico

    Actas Urologicas Espanolas

2015

  1. Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013

    European Urology, Vol. 68, Núm. 2, pp. 256-262

  2. Sequential combination of mitomycin C plus bacillus calmette-guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: Final outcome of CUETO 93009, a randomized prospective trial

    European Urology, Vol. 67, Núm. 3, pp. 508-516

  3. Surgical techniques, open versus minimally invasive gastrectomy after chemotherapy (STOMACH trial): Study protocol for a randomized controlled trial

    Trials, Vol. 16, Núm. 1

2013

  1. Resultados del proyecto docente y auditado del cáncer de recto de la Asociación Española de Cirujanos. Seis años desde su inicio

    Cirugia Espanola, Vol. 91, Núm. 8, pp. 496-503

2011

  1. The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: External validation of the EORTC risk tables

    European Urology, Vol. 60, Núm. 3, pp. 423-430

2009

  1. Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

    Journal of Urology, Vol. 182, Núm. 5, pp. 2195-2203

2008

  1. Prognostic Factors in Patients with Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials

    European Urology, Vol. 53, Núm. 5, pp. 992-1002

2007

  1. Risk factors for candidaemia in critically ill patients: A prospective surveillance study

    Mycoses, Vol. 50, Núm. 4, pp. 302-310

2005

  1. Has a 3-fold decreased dose of Bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial

    Journal of Urology, Vol. 174, Núm. 4 I, pp. 1242-1247